Research and Markets: Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8sckzv/global) has announced the addition of the "Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update" report to their offering.

Fore Pharma's latest report 'Global Oesophageal Cancer Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Oesophageal Cancer market. It covers active Oesophageal Cancer pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.

This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.

The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.

Key Topics Covered:

1. Oesophageal Cancer - Disease Overview

2. Oesophageal Cancer Pipeline Overview

3. Oesophageal Cancer Phase 3 Clinical Trial Pipeline Insights

4. Oesophageal Cancer Phase 2 Clinical Trial Pipeline Insights

5. Oesophageal Cancer Phase 1 Clinical Trial Pipeline Insights

6. Oesophageal Cancer Preclinical Research Pipeline Insights

7. Oesophageal Cancer Discovery Stage Pipeline Insights

8. Oesophageal Cancer Drug Development Activities - Geographic Landscape

8.1. Oesophageal Cancer R&D Activities in North America

8.2. Oesophageal Cancer R&D Activities in Europe

9. Oesophageal Cancer Pipeline - Licensing Activities

Table 1. Oesophageal Cancer Pipeline Molecules - Phase 3 Clinical Trial

Table 2. Oesophageal Cancer Pipeline Molecules - Phase 2 Clinical Trial

Table 3. Oesophageal Cancer Pipeline Molecules - Phase 1 Clinical Trial

Table 4. Oesophageal Cancer Pipeline Molecules - Preclinical Research

Table 5. Oesophageal Cancer Pipeline Molecules - Drug Discovery

Table 6. Oesophageal Cancer R&D Activities by Geography

Table 7. Oesophageal Cancer Pipeline Molecules - North America

Table 8. Oesophageal Cancer Pipeline Molecules - Europe

Table 9. Oesophageal Cancer Pipeline - Licensing Activities

Figure 1. Oesophageal Cancer Pipeline Molecules by R&D Stage

Figure 2. Oesophageal Cancer R&D Activities by Geography

For more information visit http://www.researchandmarkets.com/research/8sckzv/global

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals